(Q42789821)

7 November 2017

Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer (English)

1 reference

7 November 2017

2

1 reference

7 November 2017

C Mian

1

1 reference

7 November 2017

E Comploj

3

1 reference

7 November 2017

L Lusuardi

4

1 reference

7 November 2017

S Palermo

5

1 reference

7 November 2017

M Mian

6

1 reference

7 November 2017

K Maier

7

1 reference

7 November 2017

A Pycha

8

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

Journal of Clinical Pathology

7 November 2017

1 reference

7 November 2017

59

1 reference

7 November 2017

984-987

1 reference

7 November 2017

9

1 reference

Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Superficial bladder tumors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

p16(MTS-1/CDKN2/INK4a) in cancer progression

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Two molecular pathways to transitional cell carcinoma of the bladder.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

The p53 tumour suppressor gene

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Managing superficial bladder cancer: an overview

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Intermediate-risk urothelial carcinoma: an unresolved problem?

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860484

The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma

16 August 2018

1 reference

12 December 2020

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings

1 reference

12 December 2020

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

12 December 2020

Superficial bladder cancer: progression and recurrence

1 reference

12 December 2020

Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features

1 reference

12 December 2020

Fluorescence in situ hybridization identifies more aggressive types of primarily noninvasive (stage pTa) bladder cancer

1 reference

12 December 2020

Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?

1 reference

12 December 2020

Genetic alterations and biological pathways in human bladder cancer pathogenesis

1 reference

12 December 2020

Numerical chromosomal aberrations in muscle invasive squamous cell and transitional cell cancer of the urinary bladder: an alternative to classic prognostic indicators?

1 reference

12 December 2020

Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients

1 reference

12 December 2020

P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma

1 reference

12 December 2020

P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2005.035394

1 reference

7 November 2017

1 reference

7 November 2017

1 reference